Hepatitis C treatment, access and pricing
Hepatitis C treatment, access and pricing
Ministerial Resolution 929-2026/MINSA updates Peru’s national essential medicines formulary with eight HIV and hepatitis products, including a once-daily pediatric HIV tablet for about 500 children and options for more than …
Colombia’s Ministry of Health declared public interest grounds to pursue mandatory licensing of Gilead’s sofosbuvir-based hepatitis C patents, transferring the process to the competition authority for a final determination.
You must be logged in to post a comment.